Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M70,100Revenue $M23,113Net Margin (%)20.3Z-Score4.6
Enterprise Value $M70,163EPS $4.3Operating Margin %23.2F-Score5
P/E(ttm))17.8Cash Flow Per Share $5.4Pre-tax Margin (%)25.5Higher ROA y-yN
Price/Book3.910-y EBITDA Growth Rate %12.7Quick Ratio1.5Cash flow > EarningsY
Price/Sales3.15-y EBITDA Growth Rate %0.4Current Ratio2.0Lower Leverage y-yN
Price/Cash Flow9.1y-y EBITDA Growth Rate %-14.2ROA % (ttm)13.3Higher Current Ratio y-yY
Dividend Yield %3.1Insider Buy (3m)1ROE % (ttm)26.6Less Shares Outstanding y-yY
Payout Ratio %76.0Shares Outstanding M1,119ROI % (ttm)23.7Gross Margin Increase y-yN

Gurus Latest Trades with LLY

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
LLYVanguard Health Care Fund 2014-06-30 Reduce-0.15%$58.21 - $63.1
($59.62)
$ 62.625%Reduce -3.98%21,982,700
LLYPRIMECAP Management 2014-03-31 Add0.37%$50.73 - $59.85
($55.61)
$ 62.6213%Add 10.83%57,129,708
LLYJoel Greenblatt 2014-03-31 Reduce-0.16%$50.73 - $59.85
($55.61)
$ 62.6213%Reduce -93.61%9,016
LLYRay Dalio 2014-03-31 Reduce-0.01%$50.73 - $59.85
($55.61)
$ 62.6213%Reduce -34.83%31,439
LLYVanguard Health Care Fund 2013-12-31 Add0.67%$47.65 - $51.34
($50.05)
$ 62.6225%Add 22.98%22,895,000
LLYCharles Brandes 2013-12-31 Add0.19%$47.65 - $51.34
($50.05)
$ 62.6225%Add 12.57%2,711,949
LLYJoel Greenblatt 2013-12-31 Add0.11%$47.65 - $51.34
($50.05)
$ 62.6225%Add 201.79%141,121
LLYRay Dalio 2013-12-31 Add0.01%$47.65 - $51.34
($50.05)
$ 62.6225%Add 153.37%48,239
LLYVanguard Health Care Fund 2013-09-30 Add0.46%$49.92 - $54.96
($52.42)
$ 62.6220%Add 16.91%18,617,000
LLYCharles Brandes 2013-09-30 Add0.23%$49.92 - $54.96
($52.42)
$ 62.6220%Add 16.93%2,409,134
LLYPRIMECAP Management 2013-09-30 Add0.13%$49.92 - $54.96
($52.42)
$ 62.6220%Add 3.98%50,846,997
LLYDavid Dreman 2013-09-30 Buy 0.02%$49.92 - $54.96
($52.42)
$ 62.6220%New holding, 4290 sh.4,290
LLYRay Dalio 2013-09-30 Buy 0.01%$49.92 - $54.96
($52.42)
$ 62.6220%New holding, 19039 sh.19,039
LLYJohn Hussman 2013-09-30 Reduce-1.58%$49.92 - $54.96
($52.42)
$ 62.6220%Reduce -98.57%10,000
LLYJohn Hussman 2013-06-30 Add0.23%$49.06 - $58.33
($54.41)
$ 62.6215%Add 16.64%701,000
LLYPRIMECAP Management 2013-06-30 Add0.14%$49.06 - $58.33
($54.41)
$ 62.6215%Add 4.39%48,900,865
LLYJoel Greenblatt 2013-06-30 Add0.07%$49.06 - $58.33
($54.41)
$ 62.6215%Add 894.98%39,411
LLYGeorge Soros 2013-06-30 Sold Out -0.04%$49.06 - $58.33
($54.41)
$ 62.6215%Sold Out0
LLYJoel Greenblatt 2013-03-31 Buy 0.01%$49.32 - $56.79
($53.91)
$ 62.6216%New holding, 3961 sh.3,961
LLYJohn Hussman 2013-03-31 Reduce-1.03%$49.32 - $56.79
($53.91)
$ 62.6216%Reduce -57.1%601,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

LLY is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
LLY Vanguard Health Care Fund 2014-06-3021,982,7001.963.6-3.98%
LLY PRIMECAP Management 2014-03-3157,129,7085.13.8+10.83%
LLY David Dreman 2014-03-315,18200.02+8.87%
LLY John Hussman 2014-03-3110,00000.04
LLY Dodge & Cox 2014-03-3135,76000
LLY Charles Brandes 2014-03-312,703,0640.242-0.33%
LLY Mario Gabelli 2014-03-31120,9000.010.04-2.42%
LLY Ray Dalio 2014-03-3131,43900.02-34.83%
LLY Joel Greenblatt 2014-03-319,01600.01-93.61%
Premium Most recent portfolio changes are included for Premium Members only!


LLY: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
LILLY ENDOWMENT INC10% Owner 2014-07-29Sell250,000$63.03-0.63view
Mahony SusanSVP & Pres., Lilly Oncology 2014-07-28Sell2,065$63.3-1.06view
Conterno Enrique ASr. VP & Pres., Lilly Diabetes 2014-07-25Sell10,000$63.79-1.82view
Mahony SusanSVP & Pres., Lilly Oncology 2014-07-25Sell30,000$63.9-1.99view
LILLY ENDOWMENT INC10% Owner 2014-07-01Sell235,000$62.30.53view
LILLY ENDOWMENT INC10% Owner 2014-06-25Sell245,000$62.68-0.08view
LILLY ENDOWMENT INC10% Owner 2014-06-20Sell230,000$61.621.64view
LILLY ENDOWMENT INC10% Owner 2014-06-20Sell230,000$61.551.75view
LILLY ENDOWMENT INC10% Owner 2014-06-16Sell200,000$58.736.64view
LILLY ENDOWMENT INC10% Owner 2014-06-05Sell190,000$59.535.21view

Press Releases about LLY :

    Quarterly/Annual Reports about LLY:

    News about LLY:

    Articles On GuruFocus.com
    Eli Lilly is on the Right Track Jun 25 2014 
    John Paulson's Stocks Trading for Less Than He Paid for Them Jun 02 2014 
    Johnson & Johnson (JNJ) Dividend Stock Analysis May 29 2014 
    Can Pfizer Make Up Its Loss? May 09 2014 
    Will Pfizer’s Q1 2014 Earnings Beat the Street on May 5, 2014? May 05 2014 
    Vanguard Health Care Fund's Top Quarterly Holdings Apr 30 2014 
    These Three Pharmaceutical Companies Shake The Market With Their Deal Apr 27 2014 
    Forest Laboratories' Recovery Mar 18 2014 
    AstraZeneca: Time to Make a Bet? Steven Cohen Seems to Think It Is Jan 15 2014 
    Guru Stocks at 52-Week Lows: IBM, T, TLK, LLY, GLD Dec 16 2013 


    More From Other Websites
    Merck: No Tax Inversions, Just Bolt-on M&A Jul 29 2014
    [video] Big pharma tax attack Jul 29 2014
    [video] Big pharma by the numbers Jul 29 2014
    ‘Glee,’ Qualcomm, Lilly, StubHub: Intellectual Property Jul 24 2014
    Lilly beats forecasts, vows to remain independent Jul 24 2014
    [video] Facebook and Ford Gain, Wal-Mart U.S. CEO set to Leave Jul 24 2014
    UPDATE 2-Lilly beats forecasts, vows to remain independent Jul 24 2014
    Ford earnings, jobless claims to lift Wall Street Jul 24 2014
    Eli Lilly Beats on Q2 Earnings & Revs, Maintains View Jul 24 2014
    [video] Caterpillar CEO sees mining 'green shoots' Jul 24 2014
    [video] Ford Beats, GM Stalls, Eli Lilly Reports & Jim Cramer's Bank Pick Jul 24 2014
    [$$] Eli Lilly Profit Sinks on Patent Expirations Jul 24 2014
    Lilly Reports Second-Quarter 2014 Results Jul 24 2014
    [video] Eli Lilly looking for smaller acquisitions: CEO Jul 24 2014
    Q2 2014 Eli Lilly Earnings Release - Before Market Open Jul 24 2014
    [video] Results hurt by patent expirations: Eli Lilly CEO Jul 24 2014
    Eli Lilly Beats Quarterly Estimates on Diabetes Drug Sales Jul 24 2014
    Lilly beats forecasts, helped by cost controls Jul 24 2014
    Eli Lilly sees research, development charge of $45M in Q3 Jul 24 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK
    Email Hide